These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2666615)

  • 41. Total peripheral resistance during cardiac tamponade: adrenergic and angiotensin roles.
    Cogswell TL; Bernath GA; Raff H; Hoffmann RG; Klopfenstein HS
    Am J Physiol; 1986 Nov; 251(5 Pt 2):R916-22. PubMed ID: 3022609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of endogenous angiotensin II or kinin in the mechanism of altered renal vascular responsiveness to angiotensin II following acute blood volume expansion in the dog.
    Akabane S; Kojima S; Ito K; Kawamura M
    Jpn J Pharmacol; 1984 Oct; 36(2):235-40. PubMed ID: 6392654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the kinin-kallikrein system in the vasodilator action of an angiotensin converting enzyme inhibitor (captopril) on the systemic resistance and capacitance vessels of dogs.
    Ito H; Sahashi T; Hirose I; Nagata K; Wada H; Takai K; Hirakawa S
    Jpn Circ J; 1991 Sep; 55(9):857-64. PubMed ID: 1942492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure.
    Shannon RP; Friedrich S; Mathier M; Knight DR
    Cardiovasc Res; 1997 Jun; 34(3):464-72. PubMed ID: 9231029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
    McCaa RE
    Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardioprotection of ACE inhibitor in ischemic heart is not dependent on the local angiotensin II formation.
    Noda K; Sasaguri M; Ideishi M; Ikeda M; Arakawa K
    Agents Actions Suppl; 1992; 38 ( Pt 3)():217-27. PubMed ID: 1462860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetic studies of the pharmacologic response to captopril in rats. I. Role of the renin-angiotensin system.
    Endoh M; Suzuki M; Katayama K; Kakemi M; Koizumi T
    J Pharmacobiodyn; 1989 Jan; 12(1):1-9. PubMed ID: 2542516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic captopril treatment reveals the role of ANG II in cardiovascular function of embryonic American alligators (Alligator mississippiensis).
    Mueller CA; Eme J; Tate KB; Crossley DA
    J Comp Physiol B; 2018 Jul; 188(4):657-669. PubMed ID: 29623471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drugs inhibiting the renin - angiotensin system.
    Antonaccio MJ; Cushman DW
    Fed Proc; 1981 Jun; 40(8):2275-84. PubMed ID: 6263716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.
    Jeunemaître X; Ménard J; Nussberger J; Guyene TT; Brunner HR; Corvol P
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):819-27. PubMed ID: 2686709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the renin inhibitor H77 on the pressor responses to injected pig, rat and dog renins in vivo.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Hypertens; 1983 Aug; 1(2):191-5. PubMed ID: 6397517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates.
    Pals DT; DeGraaf GL; Couch SJ; Brunden MN
    Clin Exp Hypertens A; 1991; 13(3):425-36. PubMed ID: 1893613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs.
    Navar LG; Champion WJ; Thomas CE
    Circ Res; 1986 Jun; 58(6):874-81. PubMed ID: 3013463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions of the systemic and brain renin-angiotensin systems in the control of drinking and the central mediation of pressor responses.
    Robinson MM; McLennan GP; Thunhorst RL; Johnson AK
    Brain Res; 1999 Sep; 842(1):55-61. PubMed ID: 10526095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.